Literature DB >> 29448999

Quantitative perineural invasion is a prognostic marker in prostate cancer.

Sabine Lubig1, Thore Thiesler1, Stefan Müller2, Roland Vorreuther3, Norbert Leipner4, Glen Kristiansen5.   

Abstract

This study aimed to investigate the prognostic value of a quantitative, detailed, yet practical analysis of perineural invasion in radical prostatectomy specimens in a high-risk prostate cancer cohort. A total of 114 patients with prostate cancer who underwent radical prostatectomy between 2000 and 2013 were analysed. Using S100 protein immunohistochemistry assisted in the detection of nerves. In the area of closest proximity of the tumour to the dorso-lateral margins, nerves were counted and the infiltration of nerves was categorised (0-3). Category 0 was nerves without immediate tumour-cell-contact. All nerves being fully surrounded by tumour (classical perineural carcinosis) were categorised group 3. Two further categories discriminated between nerves that were touched either by carcinoma cells below 50% of the circumference (category 1) or above (category 2). Perineural carcinosis (Pn1) was seen in 61.4% of cases and correlated positively with ISUP grades, pT categories and presence of intraductal carcinoma but failed significance on Kaplan-Meier analysis. A more quantitative analysis of percentual perineural involvement did demonstrate significant survival differences: cases with less than one Pn1-positive nerve in 5 high power fields had longer survival times. Incomplete perineural involvement (category 1-2) did not have a prognostic value, endorsing the current definition of perineural carcinosis as full circumferential encasement of a nerve by tumour cells. A quantitative analysis of the percentage of nerves positive for perineural invasion has a higher prognostic value than the classical dichotomous statement on the mere presence of perineural invasion.
Copyright © 2018 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Prostate cancer; perineural carcinosis; perineural invasion; prognostic factor

Mesh:

Year:  2018        PMID: 29448999     DOI: 10.1016/j.pathol.2017.09.013

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  7 in total

Review 1.  Tumour innervation and neurosignalling in prostate cancer.

Authors:  Brayden March; Sam Faulkner; Phillip Jobling; Allison Steigler; Alison Blatt; Jim Denham; Hubert Hondermarck
Journal:  Nat Rev Urol       Date:  2020-01-14       Impact factor: 14.432

2.  A Substance P (SP)/Neurokinin-1 Receptor Axis Promotes Perineural Invasion of Pancreatic Cancer and Is Affected by lncRNA LOC389641.

Authors:  Tengfei Ji; Keqiang Ma; Hongsheng Wu; Tiansheng Cao
Journal:  J Immunol Res       Date:  2022-05-12       Impact factor: 4.493

3.  Establishment of a Convenient System for the Culture and Study of Perineurium Barrier In Vitro.

Authors:  Xuemin Yin; Xiaohao Liu; Yan Zhang; Jiao Zeng; Xiaodan Liang; Xiaojun Yang; Jin Hou
Journal:  Cell Mol Neurobiol       Date:  2020-10-07       Impact factor: 5.046

4.  Detection of perineural invasion in prostate needle biopsies with deep neural networks.

Authors:  Kimmo Kartasalo; Peter Ström; Pekka Ruusuvuori; Hemamali Samaratunga; Brett Delahunt; Toyonori Tsuzuki; Martin Eklund; Lars Egevad
Journal:  Virchows Arch       Date:  2022-04-21       Impact factor: 4.535

5.  Impact of uni- or multifocal perineural invasion in prostate cancer at radical prostatectomy.

Authors:  Alessandro Sciarra; Martina Maggi; Arianna Del Proposto; Fabio Massimo Magliocca; Antonio Ciardi; Valeria Panebianco; Ettore De Berardinis; Stefano Salciccia; Giovanni Battista Di Pierro; Alessandro Gentilucci; Alex M Kasman; Benjamin I Chung; Matteo Ferro; Ottavio de Cobelli; Francesco Del Giudice; Gian Maria Busetto; Michele Gallucci; Marco Frisenda
Journal:  Transl Androl Urol       Date:  2021-01

Review 6.  The Role of Perineural Invasion in Prostate Cancer and Its Prognostic Significance.

Authors:  Yuequn Niu; Sarah Förster; Michael Muders
Journal:  Cancers (Basel)       Date:  2022-08-23       Impact factor: 6.575

7.  Clinicopathological factors associated with pathological upgrading from biopsy to prostatectomy in patients with ISUP grade group ≤2 prostate cancer.

Authors:  Xing Li; Zhi-Xian Wang; Yun-Peng Zhu; Jing Wang; Yi-Sheng Yin; Xiao-Yong Zeng
Journal:  Asian J Androl       Date:  2022 Sep-Oct       Impact factor: 3.054

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.